NEW ADDITIONAL MESOTHELIOMA SPECIALISTS

The following physicians are specialists in the treatment of mesothelioma and have recently been added to our site. They are listed alphabetically by state with no particular endorsement.�

For a complete listing of specialists, please visit our Treatment Options page.

California

Connecticut

Illinois

New York

North Carolina

Pennsylvania

Tennessee

Texas

California
David M. Jablons, MD
Assistant Professor of Surgery Chief, General Thoracic Surgery/UCSF Mt. Zion Medical Center, San Francisco, CA
Contact: (415) 885-3882
Treatment: Dr. Jablons treatment and research specialties includes the treatment of pleural mesothelioma with pleurectomy/decortication.

Theirry Jahan, MD

2356 Sutter, 7^th Floor

San Francisco, CA 94115

Contact: (415) 567-5581

Mark Lischner, MD

2 Medical Plaza, Suite 100

Roseville, CA 95661

Contact: (916) 786-7498

Connecticut
Mark Cullen, MD

Yale University School of Medicine

Occupational and Environmental

135 College Street, 3^rd Floor

New Haven, CT 06510-2483

Illinois
Nicholas J. Vogelzang, MD
Fred C. Buffett Professor of Medicine Director, University of Chicago Cancer Center, Chicago, IL
Contact: (773) 702-6743 or Heather Brenner, RN (773) 834-0982
Treatment: Dr. Vogelzang is a nationally recognized authority on the development and testing of new anti-cancer drugs. The University of Chicago Cancer Research Center is one of the few sites selected by the National Cancer Institute (NCI) to sponsor these clinical trials in all Phases of testing.

New York
Valerie W. Rusch, FACS
Attending Thoracic Surgeon/Memorial-Sloan Kettering Cancer Center, New York, NY
Contact: (212) 639-5873
Treatment: Dr. Rusch specializes in the treatment of pleural mesothelioma. Her work is primarily focused on pleural decortication to extrapleural pneumonectomy.

Mary Louise L. Keohan, MD
Assistant Professor of Clinical Medicine, Columbia University College of Physicians and Surgeons/New York Presbyterian Hospital, New York, NY
Contact: (212) 305-4076
Treatment: Dr. Mary Louise Keohan is an oncologist, specializing in the treatment of mesothelioma and sarcoma at the Herbert Irving Comprehensive Cancer Center she is conducting multimodality studies of patients with pleural and peritoneal mesothelioma and other connective tissue oncology studies. The Center is located at Columbia University College of Physicians and Surgeons.

Roman Perez-Soler, MD
Associate Director of Clinical Oncology/New York University Kaplan Cancer Center, New York, NY
Contact: (212) 263-8043
Treatment: Dr. Perez-Soler heads up the Phase II L-NDDP/Platar trial for pleural mesothelioma.

North Carolina
David H. Harpole, Jr., MD
Associate Professor of Surgery, Thoracic Oncology Program/Assistant Professor of Pathology, Duke University Medical Center, Durham, NC
Contact: (919) 684-3683

Brian Loggie, MD

Wake Forest University Medical Center

Winston-Salem, NC 27157

Contact: (336) 716-6272 or [email protected]

Pennsylvania
Daniel Sterman, MD
Assistant Professor, Department of Medicine/University of Pennsylvania Medical Center, Philadelphia, PA
Contact: (215) 614-0984
Treatment: Dr. Sterman is the co-author of several informative articles on treatment and clinical trials for pleural mesothelioma.

Larry Kaiser, MD

University of Pennsylvania

4^th Floor

Philadephia, A 19104

Contact: (215) 662-7538

Tennessee
Spencer McCachren, MD

Thompson Cancer Center

Knoxville, TN

Contact: (423) 541-1812

Texas
Dong M. Shin, MD
Associate Professor of Medicine, Department of Medical Oncology/M. D. Anderson Cancer Center, Houston, TX
Contact: (713) 792-6363
Treatment: Dr. Shin is principal investigator of two Phase II trials and one Phase III trial for pleural mesothelioma: Phase II L-NDDP/Platar, Phase II MTA (Multitargeted Antifolate - a new IV chemotherapy designed to work in many ways at once), and Phase III Onconase/Doxorubicin.

Claire F. Verschraegen, MD
Assistant Professor, Gynecologic Med Therapeutics/M. D. Anderson Cancer Center, Houston, TX
Contact: (713) 792-7959
Treatment: Dr. Verschraegen is an expert in the treatment of peritoneal mesothelioma.